Trials
2 active
11 in total · 4 in the EU
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- COVID-19 Infection, COVID-19 SARS-CoV-2 Infection
- Main trialPhase 3
- “This is a Phase 3, randomized, actively controlled, double-blinded, double-dummy, superiority study to evaluate the efficacy and safety of ibuzatrelvir alone and in combination with remdesivir IV compared to remdesivir IV alone for the treatment of symptomatic COVID-19 in severely immunocompromised adult participants who are non-hospitalized or are hospitalized at baseline with mild-to-moderate COVID-19.”In the company’s words, NCT07013474 on ClinicalTrials.gov
- Other names
- PF-07817883
Other drugs for COVID-19 Infection
- MaravirocHealthBio, Inc. · Phase 2/3
- REGENECYTEStemCyte, Inc. · Phase 3
- VYD2311Invivyd, Inc. · Phase 3
- SecutrelvirShionogi · Phase 3
- TozorakimabAstraZeneca · Phase 3
- DAS181Ansun Biopharma, Inc. · Phase 3
Coming up2
- 28 Sep 2027Phase 3 trial completes · ClinicalTrials.gov
- 1 Oct 2027Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials11
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | 28 Sep 2027 | A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised | |
| Phase 3Recruiting | 1 Oct 2027 | A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease | |
| Phase 2Completed | 13 Sep 2023 | A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not Hospitalized | |
| Phase 1Completed | 10 Jul 2023 | A Study to Learn About How Itraconazole Affects the Blood Level of Study Medicine (PF-07817883) in Healthy Adults. | |
| Phase 1Completed | 15 Sep 2023 | A Study to Learn Safety and Blood Levels of PF-07817883 in Healthy People | |
| Phase 1Completed | 12 Jan 2024 | A Study to Learn PF-07817883 Blood Levels After Administration of Tablets of Study Drug to Healthy Adult Volunteers | |
| Phase 1Completed | 27 Jun 2024 | A Study to Learn About How Loss of Liver Function Affects the Blood Levels of the Study Medicine Called PF-07817883. | |
| Phase 1Completed | 15 Jan 2025 | A Study to Learn About if the Study Medicine Called Ibuzatrelvir Changes How the Body Process the Other Medicine Dabigatran Etexilate in Healthy Adults | |
| Phase 1Completed | 17 Jan 2025 | A Study to Learn If the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine Ibuzatrelvir in Healthy Adults | |
| Phase 1Completed | 13 Feb 2025 | A Study to Learn How Renal Impairment Affects the Pharmacokinetics of PF-07817883. | |
| Phase 1Completed | 21 Nov 2025 | A Study to Learn How the Study Medicine Called Ibuzatrelvir is Taken up Into the Blood in Healthy Chinese Adults |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026